XML 56 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and Cash Equivalents, Investments, and Funds Receivable and Amounts Held for Customers - Type of Issue (Details) - USD ($)
Apr. 30, 2023
Jul. 31, 2022
Apr. 30, 2022
Jul. 31, 2021
Cash and Cash Equivalents Items [Line Items]        
Total cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period $ 3,750,000,000 $ 2,997,000,000 $ 3,870,000,000 $ 2,819,000,000
Available-for-sale securities:        
Available-for-sale debt securities, amortized cost 729,000,000 694,000,000    
Available-for-sale debt securities, fair value 723,000,000 685,000,000    
Total cash, cash equivalents, restricted cash, restricted cash equivalents, and investments, amortized cost 4,479,000,000 3,691,000,000    
Total cash, cash equivalents, restricted cash, restricted cash equivalents, and investments, fair value 4,473,000,000 3,682,000,000    
Credit losses related to available-for-sale securities 0      
Total cash, cash equivalents, restricted cash, and restricted cash equivalents        
Cash and Cash Equivalents Items [Line Items]        
Total cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period 3,750,000,000 2,997,000,000    
Cash, cash equivalents, restricted cash, and restricted cash equivalents, fair value 3,750,000,000 2,997,000,000    
Corporate notes        
Available-for-sale securities:        
Available-for-sale debt securities, amortized cost 596,000,000 597,000,000    
Available-for-sale debt securities, fair value 591,000,000 589,000,000    
U.S. agency securities        
Available-for-sale securities:        
Available-for-sale debt securities, amortized cost 133,000,000 97,000,000    
Available-for-sale debt securities, fair value $ 132,000,000 $ 96,000,000